# COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer

> **NCT06790589** · PHASE2 · NOT_YET_RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 70 (estimated)

## Conditions studied

- Advanced Differentiated Thyroid Gland Carcinoma

## Interventions

- **DRUG:** Levothyroxine Oral Tablet [Synthroid]

## Key facts

- **NCT ID:** NCT06790589
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2027-12
- **Final completion:** 2031-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06790589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06790589, "COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06790589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*